These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35401544)

  • 21. Characterization of the Immune Resistance of Severe Acute Respiratory Syndrome Coronavirus 2 Mu Variant and the Robust Immunity Induced by Mu Infection.
    Uriu K; Cárdenas P; Muñoz E; Barragan V; Kosugi Y; Shirakawa K; Takaori-Kondo A; ; Sato K
    J Infect Dis; 2022 Sep; 226(7):1200-1203. PubMed ID: 35176774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and use of convalescent plasma in COVID-19 treatment, taking into account the experience in the Central Millitary Hospital Prague.
    Bohoněk M; Řezáč D; Holub M
    Cas Lek Cesk; 2020; 159(5):175-180. PubMed ID: 33297703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasma.
    Razumikhin M; Smolyanova T; Nikolaeva A; Orlova E; Ivanov A; Belyakova O; Vyaznikova T; Selezneva N; Perevozchikov A; Sokolova A; Zubkova N; Efimova I; Dolzhikova I; Logunov D; Sakanjan E
    Immunotherapy; 2022 Oct; 14(14):1133-1147. PubMed ID: 35892311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
    Farrugia A
    Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
    [No Abstract]   [Full Text] [Related]  

  • 25. Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titres.
    Mehew J; Johnson R; Roberts D; Griffiths A; Harvala H
    Transfus Med; 2022 Aug; 32(4):327-337. PubMed ID: 35434868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody Therapy for COVID-19: Categories, Pros, and Cons.
    Zare Marzouni H; Rahbar M; Seddighi N; Nabizadeh M; Meidaninikjeh S; Sabouni N
    Viral Immunol; 2022 Oct; 35(8):517-528. PubMed ID: 36201297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case Report: Serial Cases: Prolongation of High Immunoglobulin G Level in Repetitive COVID-19 Convalescence Plasma Donor in Saiful Anwar Hospital Malang, Indonesia.
    Nurarifah N; Brahmantyo HP; Wardhani SO; Hermanto DH; Arsana PM
    Front Immunol; 2021; 12():633323. PubMed ID: 34790190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Convalescent plasma and hyperimmune globulin therapy in COVID-19.
    Cagdas D
    Expert Rev Clin Immunol; 2021 Apr; 17(4):309-316. PubMed ID: 33620014
    [No Abstract]   [Full Text] [Related]  

  • 29. Passive immunization and its rebirth in the era of the COVID-19 pandemic.
    Pavia CS; Wormser GP
    Int J Antimicrob Agents; 2021 Mar; 57(3):106275. PubMed ID: 33400975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of SARS-CoV-2-independent immunoregulatory activity of COVID-19 convalescent plasma.
    Brox R; Achenbach S; Hackstein H
    Transfusion; 2021 Nov; 61(11):3087-3093. PubMed ID: 34546583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma.
    Sullivan D; Casadevall A
    mBio; 2023 Jun; 14(3):e0042823. PubMed ID: 37039667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
    Takamatsu Y; Imai M; Maeda K; Nakajima N; Higashi-Kuwata N; Iwatsuki-Horimoto K; Ito M; Kiso M; Maemura T; Takeda Y; Omata K; Suzuki T; Kawaoka Y; Mitsuya H
    J Virol; 2022 Feb; 96(4):e0155121. PubMed ID: 34818068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.
    Casadevall A; Henderson JP; Joyner MJ; Pirofski LA
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33621214
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.
    Zhang L; Pang R; Xue X; Bao J; Ye S; Dai Y; Zheng Y; Fu Q; Hu Z; Yi Y
    Aging (Albany NY); 2020 Apr; 12(8):6536-6542. PubMed ID: 32320384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of immunocompromised COVID-19 patients with convalescent plasma.
    Fung M; Nambiar A; Pandey S; Aldrich JM; Teraoka J; Freise C; Roberts J; Chandran S; Hays SR; Bainbridge E; DeVoe C; Roque Gardner A; Yokoe D; Henrich TJ; Babik JM; Chin-Hong P
    Transpl Infect Dis; 2021 Apr; 23(2):e13477. PubMed ID: 32989856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS COV-2- IgG antibodies in blood donors in pandemic - A game changer for policy makers.
    Mahapatra S
    Transfus Clin Biol; 2022 Feb; 29(1):11-15. PubMed ID: 34653615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
    Curtò D; Tomatis F; Gastoldi S; Galbusera M; Noris M; Raimondi F; Lorini FL; Falanga A; Marchetti M; Remuzzi G; Ruggenenti P
    Front Immunol; 2021; 12():711915. PubMed ID: 34276706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants.
    Raturi M; Kusum A; Kala M; Mittal G; Sharma A; Bansal N
    Transfus Clin Biol; 2021 Aug; 28(3):300-302. PubMed ID: 33971318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparedness and activities of the anti-SARS-CoV-2 convalescent plasma bank in the Veneto region (Italy): An organizational model for future emergencies.
    De Silvestro G; Gandini G; Fiorin F; Marson P; Barbone E; Frigato A; Gessoni G; Veronesi A; Pacenti M; Castelli M; Rinaldi M; Rizzi M; Stefani F; Roveroni G
    Transfus Apher Sci; 2021 Aug; 60(4):103154. PubMed ID: 33994107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives for immune plasma treatment of COVID-19.
    Sayinalp B; Çinar OE; Haznedaroğlu İC
    Turk J Med Sci; 2021 Feb; 51(1):1-9. PubMed ID: 32718128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.